Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Randomized Trial to Evaluate the Virologic Response and Pharmacokinetics of Two Different Potent Regimens in HIV Infected Women Initiating Triple Antiretroviral Regimens Between 20 and 36 Weeks of Pregnancy for the Prevention of Mother-to-Child Transmission: NICHD P1081

NCT01618305 is registered in ClinicalTrials.gov with Westat as lead sponsor.

NCT NCT01618305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01618305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Randomized Trial to Evaluate the Virologic Response and Pharmacokinetics of Two Different Potent Regimens in HIV Infected Women Initiating Triple Antiretroviral Regimens Between 20 and 36 Weeks of Pregnancy for the Prevention of Mother-to-Child Transmission: NICHD P1081
Lead sponsor
Westat
Phase
Phase 4
Overall status
Completed
Start date
September 5, 2013
Completion date
December 11, 2018
Enrollment
408 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections